-+ 0.00%
-+ 0.00%
-+ 0.00%

BioXcel Therapeutics Announces Allowance of U.S. Patent Application for Igalmi Dosing Regimen in Treating Acute Agitation

Reuters·07/15/2025 12:02:31

Please log in to view news